[1]
2024. SGLT2i pharmacological treatment in type 2 diabetes mellitus control and its underlying obesity. Revista Portuguesa de Medicina Geral e Familiar. 40, 2 (Abr. 2024), 148–56. DOI:https://doi.org/10.32385/rpmgf.v40i2.13647.